Recent advances in neuro-ophthalmology.
| Autor: | Bassi ST; Neuro Ophthalmology Services, Sankara Nethralaya, Chennai, Tamil Nadu, India., Newman NJ; Departments of Ophthalmology, Neurology and Neurological Surgery, Emory University School of Medicine, Atlanta, Georgia, USA., Chen JJ; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota (MN), USA.; Department of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA., Tisavipat NY; Department of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA., Mollan SP; Birmingham Neuro-Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom (UK).; Translational Brain Science, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK., Moss HE; Department of Ophthalmology, Neurology and Neurological Sciences, Stanford University, Palo Alto, California, USA., Milea D; Visual Neuroscience Group, Singapore Eye Research Institute and Duke NUS, Medical School, Singapore.; Rothschild Foundation Hospital, Paris, France. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Indian journal of ophthalmology [Indian J Ophthalmol] 2024 Nov 01; Vol. 72 (11), pp. 1544-1559. Date of Electronic Publication: 2024 Oct 26. |
| DOI: | 10.4103/IJO.IJO_594_24 |
| Abstrakt: | This review article represents a collaborative effort across continents, bringing together the latest developments in neuro-ophthalmology with a focus on innovative diagnostic and therapeutic modalities that are shaping the future of the field. Among the most significant advancements is the rise of optical coherence tomography (OCT), now recognized as an indispensable tool in neuro-ophthalmological research, providing unparalleled insights into optic nerve and central nervous system pathologies. Gene therapy, particularly for conditions such as Leber's hereditary optic neuropathy, marks a new frontier in personalized medicine, offering hope for previously untreatable conditions. The article also examines the transformative role of telemedicine and artificial intelligence (AI) in clinical practice, which are revolutionizing patient care and enhancing diagnostic precision. Furthermore, it highlights the impact of novel serological biomarkers on the understanding and management of immune-mediated optic neuritis, and discusses the introduction of new therapeutic agents like Tocilizumab and Teprotumumab, which are redefining treatment paradigms. Collectively, these advancements reflect the profound influence of modern medicine on neuro-ophthalmology, paving the way for improved patient outcomes and fostering new avenues for research and clinical practice. (Copyright © 2024 Copyright: © 2024 Indian Journal of Ophthalmology.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|